Need well-designed protocol with statistically validated sample size: CDSCO panel tells Dr Reddy's Labs on Nerivio

Published On 2023-06-06 08:58 GMT   |   Update On 2023-06-06 08:58 GMT
Advertisement

In line with the proposal to conduct a pivotal clinical investigation of the proposed product Nerivio, the Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) has opined the pharmaceutical giant Dr. Reddy's laboratories that the study should be under a scientifically robust, well-designed protocol with a statistically validated sample size.

In regards to the above, the expert panel suggested the firm submit a revised protocol for further review by the committee.

Advertisement

For more details, check out the link given below:

Need well-designed protocol with statistically validated sample size: CDSCO Panel Tells Dr. Reddy's on Nerivio

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News